Stem cell transplantation procedure results in long-term survival for amyloidosis patients
(Boston) � Researchers from the Stem Cell Transplant Program and the Amyloid Treatment and Research Program at Boston University Medical Center (BUMC) have found that high-dose chemotherapy and blood stem cell transplantation can result in long-term survival for patients diagnosed with primary systemic light chain (AL) Amyloidosis.The findings appear prepublished in the First Edition of […]
Previous Stories
- Not all embryonic stem cell lines are created equal
- UCF research links proteins, stem cells and potential Alzheimer’s treatment
- Cancer stem cells can go it alone
- Dartmouth professor makes case for ethically universal stem cell lines
- Stanford researchers find stem cells in colorectal tumors
- Stanford researchers track human stem cells transplanted into rat brain
- Existence of muscle-building stem cells points to regenerative therapies for muscular disease
- Human stem cell treatment restores motor function in paralyzed rats
- Master regulatory gene of epithelial stem cells identified
- Researchers urge caution in using ESAs for cancer-related anemia
- Unstable leukemia stem cells may predispose patients to drug resistance
- Stem cells provide new tool for studying disease and identifying ALS drugs
- The sturdier sex? — Study by Pittsburgh scientists finds female stem cells work better
- Study shows isolation of stem cells may lead to a treatment for hearing loss
- Stem cell therapy shows promise for rescuing deteriorating vision
- Stem cells speed growth of healthy liver tissue
- Immune response to cancer stem cells may dictate cancer’s course
- Chemical cues turn embryonic stem cells into cerebellar neurons
